Designing liposomal adjuvants for the next generation of vaccines

Yvonne Perrie, Fraser Crofts, Andrew Devitt, Helen R Griffiths, Elisabeth Kastner, Vinod Nadella

Research output: Contribution to journalArticle

Abstract

Liposomes not only offer the ability to enhance drug delivery, but can effectively act as vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and composition allow for targeted antigen delivery via a range of administration routes. In the development of liposomal adjuvants, the type of immune response promoted has been linked to their physico-chemical characteristics, with the size and charge of the liposomal particles impacting on liposome biodistribution, exposure in the lymph nodes and recruitment of the innate immune system. The addition of immunostimulatory agents can further potentiate their immunogenic properties. Here, we outline the attributes that should be considered in the design and manufacture of liposomal adjuvants for the delivery of sub-unit and nucleic acid based vaccines.

LanguageEnglish
Pages85-96
Number of pages12
JournalAdvanced Drug Delivery Reviews
Volume99
Issue numberPart A
Early online date11 Nov 2015
DOIs
Publication statusPublished - 1 Apr 2016

Fingerprint

Liposomes
Vaccines
DNA Vaccines
Immune System
Lymph Nodes
Antigens
Pharmaceutical Preparations

Bibliographical note

© 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

Funding: EPSRC, Aston University, Novartis and an Nc3R grant

Keywords

  • liposomes
  • vaccines
  • adjuvants
  • antigens
  • delivery systems
  • microfluidics
  • QbD
  • MVA

Cite this

Perrie, Y., Crofts, F., Devitt, A., Griffiths, H. R., Kastner, E., & Nadella, V. (2016). Designing liposomal adjuvants for the next generation of vaccines. Advanced Drug Delivery Reviews, 99(Part A), 85-96. https://doi.org/10.1016/j.addr.2015.11.005
Perrie, Yvonne ; Crofts, Fraser ; Devitt, Andrew ; Griffiths, Helen R ; Kastner, Elisabeth ; Nadella, Vinod. / Designing liposomal adjuvants for the next generation of vaccines. In: Advanced Drug Delivery Reviews. 2016 ; Vol. 99, No. Part A. pp. 85-96.
@article{1b5373cbe3474a0da6fe8921466299a0,
title = "Designing liposomal adjuvants for the next generation of vaccines",
abstract = "Liposomes not only offer the ability to enhance drug delivery, but can effectively act as vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and composition allow for targeted antigen delivery via a range of administration routes. In the development of liposomal adjuvants, the type of immune response promoted has been linked to their physico-chemical characteristics, with the size and charge of the liposomal particles impacting on liposome biodistribution, exposure in the lymph nodes and recruitment of the innate immune system. The addition of immunostimulatory agents can further potentiate their immunogenic properties. Here, we outline the attributes that should be considered in the design and manufacture of liposomal adjuvants for the delivery of sub-unit and nucleic acid based vaccines.",
keywords = "liposomes, vaccines, adjuvants, antigens, delivery systems, microfluidics, QbD, MVA",
author = "Yvonne Perrie and Fraser Crofts and Andrew Devitt and Griffiths, {Helen R} and Elisabeth Kastner and Vinod Nadella",
note = "{\circledC} 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Funding: EPSRC, Aston University, Novartis and an Nc3R grant",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.addr.2015.11.005",
language = "English",
volume = "99",
pages = "85--96",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "Part A",

}

Perrie, Y, Crofts, F, Devitt, A, Griffiths, HR, Kastner, E & Nadella, V 2016, 'Designing liposomal adjuvants for the next generation of vaccines' Advanced Drug Delivery Reviews, vol. 99, no. Part A, pp. 85-96. https://doi.org/10.1016/j.addr.2015.11.005

Designing liposomal adjuvants for the next generation of vaccines. / Perrie, Yvonne; Crofts, Fraser; Devitt, Andrew; Griffiths, Helen R; Kastner, Elisabeth; Nadella, Vinod.

In: Advanced Drug Delivery Reviews, Vol. 99, No. Part A, 01.04.2016, p. 85-96.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Designing liposomal adjuvants for the next generation of vaccines

AU - Perrie, Yvonne

AU - Crofts, Fraser

AU - Devitt, Andrew

AU - Griffiths, Helen R

AU - Kastner, Elisabeth

AU - Nadella, Vinod

N1 - © 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Funding: EPSRC, Aston University, Novartis and an Nc3R grant

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Liposomes not only offer the ability to enhance drug delivery, but can effectively act as vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and composition allow for targeted antigen delivery via a range of administration routes. In the development of liposomal adjuvants, the type of immune response promoted has been linked to their physico-chemical characteristics, with the size and charge of the liposomal particles impacting on liposome biodistribution, exposure in the lymph nodes and recruitment of the innate immune system. The addition of immunostimulatory agents can further potentiate their immunogenic properties. Here, we outline the attributes that should be considered in the design and manufacture of liposomal adjuvants for the delivery of sub-unit and nucleic acid based vaccines.

AB - Liposomes not only offer the ability to enhance drug delivery, but can effectively act as vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and composition allow for targeted antigen delivery via a range of administration routes. In the development of liposomal adjuvants, the type of immune response promoted has been linked to their physico-chemical characteristics, with the size and charge of the liposomal particles impacting on liposome biodistribution, exposure in the lymph nodes and recruitment of the innate immune system. The addition of immunostimulatory agents can further potentiate their immunogenic properties. Here, we outline the attributes that should be considered in the design and manufacture of liposomal adjuvants for the delivery of sub-unit and nucleic acid based vaccines.

KW - liposomes

KW - vaccines

KW - adjuvants

KW - antigens

KW - delivery systems

KW - microfluidics

KW - QbD

KW - MVA

UR - http://www.scopus.com/inward/record.url?scp=84960230446&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2015.11.005

DO - 10.1016/j.addr.2015.11.005

M3 - Article

VL - 99

SP - 85

EP - 96

JO - Advanced Drug Delivery Reviews

T2 - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - Part A

ER -